Alert: Rating Downgrade (3/21/25)-Adverum Biotechnologies Inc (NASDAQ: ADVM).
Stock Rating Downgrade Recently the Value Trend Rating for Adverum Biotechnologies Inc (NASDAQ: ADVM) weakened from C to D reflecting eroding fundamentals and low Appreciation Potential. Recent Price Action Adverum Biotechnologies Inc (NASDAQ: ADVM) stock […]
